当前位置:首页 - 行情中心 - 广济药业(000952) - 财务分析 - 现金流量表

广济药业

(000952)

  

流通市值:22.84亿  总市值:23.02亿
流通股本:3.44亿   总股本:3.47亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金303,361,830.08152,662,820.51906,178,631.73725,030,748.99
  收到的税费返还16,850,632.052,817,563.3259,360,408.6913,892,745.38
  收到其他与经营活动有关的现金7,258,553.178,695,872.7983,581,707.0219,675,427.93
  经营活动现金流入小计327,471,015.3164,176,256.621,049,120,747.44758,598,922.3
  购买商品、接受劳务支付的现金174,916,815.190,403,742.22706,053,107.36541,972,437.36
  支付给职工以及为职工支付的现金70,565,852.6239,317,241.58171,648,380.14136,577,649.58
  支付的各项税费14,272,779.118,549,952.425,741,480.2118,214,388.15
  支付其他与经营活动有关的现金42,452,967.3426,489,964.66145,022,422.33109,981,563.48
  经营活动现金流出小计302,208,414.17164,760,900.861,048,465,390.04806,746,038.57
  经营活动产生的现金流量净额25,262,601.13-584,644.24655,357.4-48,147,116.27
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额--2,156,281.78-
  处置子公司及其他营业单位收到的现金净额44,786,222.0244,786,222.02--
  投资活动现金流入的平衡项目000-
  投资活动现金流入小计44,786,222.0244,786,222.022,156,281.78-
  购建固定资产、无形资产和其他长期资产支付的现金23,676,518.817,527,217.15154,931,562.81110,451,824.42
  投资活动现金流出小计23,676,518.817,527,217.15154,931,562.81110,451,824.42
  投资活动产生的现金流量净额21,109,703.2137,259,004.87-152,775,281.03-110,451,824.42
三、筹资活动产生的现金流量:
  吸收投资收到的现金--2,000,0002,000,000
  其中:子公司吸收少数股东投资收到的现金--2,000,0002,000,000
  取得借款收到的现金486,661,000360,940,000766,306,480393,737,480
  收到其他与筹资活动有关的现金250,000,000--255,000,000
  筹资活动现金流入小计736,661,000360,940,000768,306,480650,737,480
  偿还债务支付的现金531,444,065.85271,061,400.06660,488,581.5270,795,000
  分配股利、利润或偿付利息支付的现金27,211,085.9611,776,178.250,461,528.5145,311,064.41
  支付其他与筹资活动有关的现金22,348,869-14,513,784179,187,649.86
  筹资活动现金流出小计581,004,020.81282,837,578.26725,463,894.01495,293,714.27
  筹资活动产生的现金流量净额155,656,979.1978,102,421.7442,842,585.99155,443,765.73
四、汇率变动对现金及现金等价物的影响1,200,572.93407,285.071,211,055.972,120,230.98
五、现金及现金等价物净增加额203,229,856.46115,184,067.44-108,066,281.67-1,034,943.98
  加:期初现金及现金等价物余额307,177,265.18307,177,265.18415,243,546.85415,243,546.85
  期末现金及现金等价物余额510,407,121.64422,361,332.62307,177,265.18414,208,602.87
补充资料:
  净利润-82,303,764.28--315,134,061.79-
  资产减值准备2,058,122.98-31,810,540.68-
  固定资产和投资性房地产折旧77,224,568.28-157,953,771.85-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧77,224,568.28-157,953,771.85-
  无形资产摊销3,183,536.08-6,246,765.6-
  长期待摊费用摊销930,919.4-1,918,005.13-
  处置固定资产、无形资产和其他长期资产的损失--2,402,290.22-
  固定资产报废损失--1,737,915.53-
  财务费用26,434,422.46-61,976,137.73-
  投资损失--27,920,916.28-
  递延所得税554,342.67--5,040,709.69-
  其中:递延所得税资产减少617,056.75--4,852,869.68-
    递延所得税负债增加-62,714.08--187,840.01-
  存货的减少-35,562,029.33--14,164,374.96-
  经营性应收项目的减少-70,643,992.61-156,170,677.51-
  经营性应付项目的增加112,570,932.59--114,201,913.22-
  其他-9,522,282.92-119,517.52-
  现金的期末余额510,407,121.64-307,177,265.18-
  减:现金的期初余额307,177,265.18-415,243,546.85-
  现金及现金等价物的净增加额203,229,856.46--108,066,281.67-
公告日期2025-08-292025-04-282025-04-282024-10-31
审计意见(境内)带强调事项段的无保留意见
TOP↑